OMEPRAZOLE ZENTIVA CONSEIL 20 mg, gélule — plaquette(s) PVC PVDC aluminium de 14 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930320198
  • CIP7 3032019
  • CIS 65728544

What the source publishes

Holder
ZENTIVA FRANCE
Active ingredients
OMÉPRAZOLE
Form
gélule
Package
plaquette(s) PVC PVDC aluminium de 14 gélule(s)
Routes
orale
Administrative status
authorised
Marketing status
Déclaration de commercialisation
Authorised on
2025-05-27

Names this record is found by

Complete source data
fr:ansm:packages:3400930320198
{
  "cis": "65728544",
  "cip7": "3032019",
  "form": "gélule",
  "name": "OMEPRAZOLE ZENTIVA CONSEIL 20 mg, gélule — plaquette(s) PVC PVDC aluminium de 14 gélule(s)",
  "cip13": "3400930320198",
  "holder": "ZENTIVA FRANCE",
  "routes": [
    "orale"
  ],
  "holders": [
    "ZENTIVA FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2025-05-27",
  "compositions": [
    {
      "name": "OMÉPRAZOLE",
      "nature": "SA",
      "strength": "20 mg",
      "linkageNumber": "1",
      "substanceCode": "04773",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": null,
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "OMEPRAZOLE ZENTIVA CONSEIL 20 mg, gélule",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) PVC PVDC aluminium de 14 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2025-12-17",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "unknown",
  "activeIngredientNames": [
    "OMÉPRAZOLE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930320198"